Studying The Epigenetics Of Hormone Therapy Resistance Leads To New Drug Target

[News]

A team of international cancer researchers led by Dr. Mathieu Lupien at the Princess Margaret Cancer Centre, University Health Network, has identified the signalling pathway that is over-activated in estrogen receptor (ER)-positive breast cancer cells that are resistant to hormone therapies such as tamoxifen, aromatase inhibitors or fulvestrant...

More... (http://www.medicalnewstoday.com/releases/258478.php)